New York Life Investment Management »

Immunitybio shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $960k 191k 5.02
2023-09-30 $331k 196k 1.69
2023-06-30 $630k 226k 2.78
2023-03-31 $478k 263k 1.82

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Geode Capital Management
Susquehanna International
Credit Suisse
Jpmorgan Chase & Co
Northern Trust
Rafferty Asset Management
Bank of America Corporation
Goldman Sachs Group
Charles Schwab Investment Management
Citigroup
Perceptive Advisors
Citadel Advisors
Sheets Smith Wealth Management

View all funds holding Immunitybio